Market
Countable Labs raises $26m for PCR technology advancement
Countable Labs closed a $26 million funding round to advance its PCR technology platform, which the company claims delivers at least tenfold sensitivity improvement over conventional PCR. The capital will support product development and commercialization of the diagnostic tool.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network